Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 136.40
+1.35 (1.00%)
At close: Sep 21, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 938.28 million as of September 25, 2026. Its market cap has increased by 661.82% in one year.
Market Cap
938.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
136.40
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 938.28M, an increase of 1,281.76%. That is a compound annual growth rate of 44.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 938.28M | 641.32% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Speciality Medicines | 1.30B |
| Aayush Wellness | 1.18B |
| Godavari Drugs | 1.11B |
| Makers Laboratories | 1.10B |
| Asston Pharmaceuticals | 1.06B |
| Pharmaids Pharmaceuticals | 1.05B |
| Concord Drugs | 999.06M |
| Mercury Laboratories | 978.06M |